IAN MORTIMER

Insider Reports History

Location
Burnaby
Signature
/s/ Nathaniel Adams, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by IAN MORTIMER:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xenon Pharmaceuticals Inc. PRESIDENT & CEO, Director Common Shares 14,731 $885,450 $60.11 10 Mar 2026 Direct
Xenon Pharmaceuticals Inc. PRESIDENT & CEO, Director Common Shares 14,300 $640,926 $44.82 09 Mar 2026 By Spouse
Xenon Pharmaceuticals Inc. PRESIDENT & CEO, Director Share Option (Right to Buy) 350,000 09 Jan 2026 Direct
Xenon Pharmaceuticals Inc. PRESIDENT & CEO, Director Restricted Share Units 65,000 09 Jan 2026 Direct
Xenon Pharmaceuticals Inc. PRESIDENT & CEO, Director Performance Share Units 0 09 Mar 2026 Direct
Xenon Pharmaceuticals Inc. PRESIDENT & CEO, Director Stock Option 0 09 Mar 2026 Direct
Xenon Pharmaceuticals Inc. PRESIDENT & CEO, Director Stock Option (Right to Buy) 0 02 Jan 2026 Direct

Insider Reports Filed by IAN MORTIMER

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XENE Xenon Pharmaceuticals Inc. 09 Mar 2026 21 -$16,966,500 4 PRESIDENT & CEO, Director 11 Mar 2026, 19:20
XENE Xenon Pharmaceuticals Inc. 09 Jan 2026 2 $0 4 PRESIDENT & CEO, Director 09 Jan 2026, 18:51
XENE Xenon Pharmaceuticals Inc. 02 Jan 2026 4 -$1,477,493 4 PRESIDENT & CEO, Director 02 Jan 2026, 18:49
XENE Xenon Pharmaceuticals Inc. 05 Dec 2025 3 -$1,142,513 4 PRESIDENT & CEO, Director 09 Dec 2025, 19:40
XENE Xenon Pharmaceuticals Inc. 28 Nov 2025 1 -$4,366 4 PRESIDENT & CEO, Director 03 Dec 2025, 20:20
XENE Xenon Pharmaceuticals Inc. 01 Oct 2025 3 -$811,750 4 PRESIDENT, CEO & INTERIM CFO, Director 01 Oct 2025, 19:17
XENE Xenon Pharmaceuticals Inc. 12 Mar 2025 2 $0 4 PRESIDENT & CEO, Director 13 Mar 2025, 19:33
XENE Xenon Pharmaceuticals Inc. 23 Jan 2025 11 -$1,237,197 4 PRESIDENT & CEO, Director 27 Jan 2025, 20:28
XENE Xenon Pharmaceuticals Inc. 11 Mar 2024 1 $0 4 PRESIDENT & CEO, Director 12 Mar 2024, 18:33
XENE Xenon Pharmaceuticals Inc. 24 May 2023 12 -$1,163,499 4 PRESIDENT & CEO, Director 26 May 2023, 19:10
XENE Xenon Pharmaceuticals Inc. 10 Mar 2023 1 $0 4 PRESIDENT & CEO, Director 14 Mar 2023, 16:36
XENE Xenon Pharmaceuticals Inc. 10 Mar 2022 1 $0 4 PRESIDENT & CEO, Director 14 Mar 2022, 16:15
XENE Xenon Pharmaceuticals Inc. 03 Jun 2021 1 $0 4 PRESIDENT & CEO, Director 03 Jun 2021, 16:46